No Data
No Data
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
GLP-1 market leaders Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday, as new weight-loss drugs from rival pharmaceutical companies began threatening the dominance of their flagship products, Zepbound and Wegovy.
Form 144 | Terns Pharmaceuticals(TERN.US) Director Proposes to Sell 9.09 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 15, $Terns Pharmaceuticals(TERN.US)$ Director OrbiMed Private Investments VII, LP intends to sell 976.8K shares of its common stock on Jul 15, with a total market value
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
Mizuho Securities analyst Graig Suvannavejh maintains $Terns Pharmaceuticals(TERN.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 46.2% and a total average
Mizuho Securities Keeps Their Buy Rating on Terns Pharmaceuticals (TERN)
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Conagra Brands, Inc. (NYSE:CAG) fell during Thursday's session after the company reported worse-than-expected fourth-quarter sales results and issued FY25 adjusted EPS guidance below
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mostly higher, with the Dow Jones index gaining around 100 points on Thursday.Shares of Methode Electronics, Inc. (NYSE:MEI) rose sharply during Thursday's session after the company
No Data